Furthermore, CYR61 is involved in inflammatory and fibrotic responses, which can create a tumor-promoting microenvironment; targeting CYR61 can thus alter this microenvironment to be less supportive of cancer progression [21,22]. Here, CCN1 is linked to neoplasm.